Alpha Lipoic Acid and Diabetic Neuropathy: Evidence Review

What Is Alpha Lipoic Acid?

Alpha lipoic acid (ALA) is a naturally occurring antioxidant found in every cell of the human body. Unlike most antioxidants, ALA is both water- and fat-soluble, allowing it to work throughout the body's tissues. It plays a critical role in mitochondrial energy metabolism and helps neutralize harmful free radicals that damage nerves — a key concern for people living with diabetes.

Understanding Diabetic Neuropathy

Diabetic neuropathy is one of the most common and debilitating complications of diabetes, affecting up to 50% of people with type 1 or type 2 diabetes. It occurs when chronically high blood glucose levels damage peripheral nerves, leading to symptoms such as:

• Burning or shooting pain in the feet and legs
• Tingling or numbness
• Loss of balance and coordination
• Muscle weakness

Oxidative stress is a major driver of nerve damage in diabetes, making antioxidant therapies like ALA a logical and well-studied intervention.

The Clinical Evidence for ALA

Alpha lipoic acid has been studied more extensively for diabetic neuropathy than almost any other nutritional supplement. Here is what the research shows:

ALADIN Trials

The Alpha-Lipoic Acid in Diabetic Neuropathy (ALADIN) trials conducted in Germany during the 1990s were landmark studies. The ALADIN I trial demonstrated that intravenous ALA at 600 mg/day significantly reduced symptoms of polyneuropathy — including pain, burning, and numbness — compared to placebo after just three weeks of treatment.

SYDNEY and SYDNEY 2 Trials

The SYDNEY 2 trial, published in Diabetes Care, evaluated oral ALA supplementation. Participants taking 600 mg of oral ALA daily for five weeks experienced meaningful reductions in the Total Symptom Score (TSS), a validated measure of neuropathic symptoms. Higher doses (1,200 mg and 1,800 mg) offered no additional benefit and increased the risk of side effects.

NATHAN 1 Trial

This longer-term trial followed participants for four years. While it did not meet its primary endpoint for nerve conduction improvement, it did show a statistically significant benefit in neuropathy impairment scores, suggesting ALA may slow neuropathy progression over time.

How ALA Works Against Neuropathy

ALA combats diabetic neuropathy through several complementary mechanisms:

• Antioxidant activity: ALA scavenges reactive oxygen species that damage nerve cells and myelin sheaths.
• Nerve blood flow: ALA improves endoneurial blood flow, helping deliver oxygen and nutrients to nerves.
• Insulin sensitivity: ALA activates GLUT4 transporters, improving glucose uptake and reducing the toxic glucose burden on nerves.
• Regeneration support: Emerging evidence suggests ALA may support nerve fiber regeneration in damaged peripheral nerves.

Recommended Dosage and Forms

Based on clinical trial data, the most supported oral dose is 600 mg of ALA per day, typically taken 30–60 minutes before meals for optimal absorption. Intravenous ALA (600 mg/day) has shown faster results in acute settings but requires medical supervision.

ALA is available in two forms: R-ALA (the natural, biologically active form) and S-ALA (synthetic). R-ALA is generally considered more bioavailable and potent, though many commercial supplements contain a racemic mixture of both.

Safety and Considerations

ALA is generally well tolerated. The most commonly reported side effects include nausea, vomiting, and skin rashes — typically at doses above 600 mg. Importantly, ALA can lower blood glucose levels, so people taking insulin or oral diabetes medications should monitor blood sugar carefully and consult their healthcare provider before starting supplementation. Those with thiamine (vitamin B1) deficiency should address this prior to ALA use.

Practical Takeaway

The body of evidence supporting alpha lipoic acid for diabetic neuropathy symptom relief is among the strongest for any dietary supplement in diabetes care. While it is not a replacement for blood sugar management or prescribed medications, 600 mg of oral ALA daily represents a reasonable, evidence-backed adjunct therapy for adults experiencing neuropathic symptoms. Always discuss supplementation with your endocrinologist or diabetes care team before beginning.